Tarsons Products Limited

Web: tarsons.com NSE: TARSONS BSE: 543399 SECTOR: Healthcare - Healthcare Equipment & Supplies | Add Note | View Notes

334 2(-1%)

Volume

1L as on 23, Jun

Open

394

High

399

Low

393

336

VWAP

265

52 Week High

375

52 Week Low

164

Viand Research Rating

Quality Score

0/100

Growth Score

37/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,777

No. of Shares

5.32

P/E

45.35

P/B

3.53

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

7.78

ROCE

Profit Growth

Listing Date

26-Nov-21

Promoter Holding

47.3%

FII Holding

0.15%

DII Holding

0.1%

Price Chart

Price Performance

1 Week10%

1 Month20%

3 Months48%

6 Months35%

1 Year35%

YTD35%

Moving Average

5 Day SMA268

10 Day SMA240

20 Day SMA226

30 Day SMA221

50 Day SMA219

61 Day SMA212

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	285	273	278	288
Resistance 2	278	272	274	280
Resistance 1	274	271	272	278
Pivot Point	268	270	268	270
Support 1	264	269	264	267
Support 2	258	269	262	259
Support 3	254	268	258	257

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 47.30%	(0.01) 47.30%	(0.01) 47.30%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.30%
FIIs	(-0.71) 0.15%	(-1.61) 0.87%	(-3.41) 2.46%	(-3.31) 5.82%	(-0.41) 9.14%	(2.01) 9.53%	(-0.51) 7.51%	(0.11) 8.04%	(-0.21) 7.95%	(1.31) 8.16%	(-1.01) 6.83%	(-0.81) 7.85%	(-0.51) 8.64%	(-0.41) 9.16%	(-0.31) 9.60%	(0.61) 9.90%	(0.21) 9.33%	(-0.21) 9.12%	(0.01) 9.33%
DIIs	(-0.11) 0.10%	(0.21) 0.19%	(-0.11) 0.00%	(0.01) 0.08%	(-0.31) 0.04%	(-0.21) 0.30%	(0.31) 0.51%	(0.11) 0.21%	(-0.11) 0.11%	(-2.41) 0.17%	(-0.61) 2.60%	(-4.21) 3.15%	(-1.11) 7.38%	(-0.11) 8.45%	(0.41) 8.52%	(0.11) 8.13%	(0.31) 8.06%	(1.41) 7.76%	(0.01) 6.33%
Public	52.44%	51.65%	50.23%	46.79%	43.50%	42.89%	44.69%	44.45%	44.63%	44.36%	43.27%	41.68%	36.67%	35.09%	34.59%	34.67%	35.31%	35.82%	37.04%
No. of Shareholders	83,453	84,093	87,336	88,966	90,891	93,417	96,927	99,586	105,330	102,866	107,564	108,236	107,440	105,304	107,945	107,011	112,227	125,714	159,891

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020
Sales	110.24	120.93	107.89	102.33	91.36	112.69	95.68	99.25	84.8	105.72	61.79	84.94	70.66	76.05	69.15	67.56	60.23
Sales Growth % (YoY)	20.7%	7.3%	12.8%	3.1%	7.7%	6.6%	54.8%	-	-	-	-	25.7%	17.3%	-	-	-	-
Sales Growth % (QoQ)	-8.8%	12.1%	5.4%	12%	-18.9%	17.8%	-3.6%	17%	-19.8%	71.1%	-27.3%	20.2%	-7.1%	10%	2.4%	12.2%	-
Expenses	84.25	86.66	76.37	74.88	66.66	75.67	66.04	73.94	66.04	75.48	38.91	40.61	37.52	37.58	32.39	32.71	29.56
Operating Profit	25.99	34.27	31.52	27.45	24.7	37.02	29.64	25.31	18.76	30.24	22.88	44.33	33.14	38.47	36.76	34.85	30.67
OPM %	23.58	28.34	29.21	26.82	27.04	32.85	30.98	25.5	22.12	28.6	37.03	52.19	46.9	50.59	53.16	51.58	50.92
Other Income	5.98	6.83	7.07	5.8	3.34	3.78	0.85	8.43	2.91	3.38	3.24	2.58	2.46	1.45	1.98	0.66	1.81
Interest	6.27	6.25	6.05	5.18	5.07	5.2	5.03	4.84	4.32	4.25	2.51	0.45	1.37	1.56	0.83	0.58	0.75
Depreciation	27.02	29.08	25.04	22.48	19.94	20.03	17.41	14.03	11.03	12.33	10.06	7.24	5.35	4.81	4.57	3.37	3.46
Profit before tax	-1.32	5.77	7.5	5.59	3.03	15.57	8.05	14.87	6.32	17.04	13.55	39.22	28.88	33.55	33.34	31.56	28.27
Tax %	9.09	27.56	32.93	40.61	41.25	34.49	34.66	30.8	36.39	39.5	26.72	24.89	25.66	25.78	25.52	25.35	25.54
Net Profit	-1.44	4.18	5.04	3.32	1.78	10.2	5.26	10.29	4.02	10.32	9.93	29.46	21.47	24.9	24.84	23.56	21.05
Net Profit Growth % (QoQ)	-134.4%	-17.1%	51.8%	86.5%	-82.5%	93.9%	-48.9%	156%	-61%	3.9%	-66.3%	37.2%	-13.8%	0.2%	5.4%	11.9%	-
Net Profit Growth % (YoY)	-180.9%	-59%	-4.2%	-67.7%	-55.7%	-1.2%	-47%	-	-	-	-	25%	2%	-	-	-	-
TTM Net Profit	11.1	14.32	20.34	20.56	27.53	29.77	29.89	34.56	24.27	20.25	9.93	100.67	94.77	94.35	69.45	44.61	0
EPS in Rs	-0.27	0.79	0.95	0.62	0.33	1.92	0.99	1.93	0.76	1.94	1.87	5.54	4.04	4.89	4.88	1225.81	1095.21

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2022	Mar 2021
Sales	423	392	296	301	229
Sales Growth %	7.7%	32.4%	-	31.4%	-
Expenses	305	282	196	148	125
Operating Profit	118	111	100	153	103
OPM %	28	28	34	51	45
Other Income	23	16	11	8	5
Interest	23	20	10	4	3
Depreciation	97	62	40	22	14
Profit before tax	22	45	61	135	92
Tax %	35	34	30	25	25
Net Profit	14	30	43	101	69
Net Profit Growth %	-53.3%	-30.2%	-57.4%	46.4%	-
EPS in Rs	2.69	5.6	8.01	18.92	3583.25
Dividend Payout %	0	0	25	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2022	Mar 2021
Cash from Operating Activity	118	114	103	83	68
Cash from Investing Activity	-130	-145	-285	-138	-64
Cash from Financing Activity	9	39	136	130	-27
Net Cash Flow	-3	8	-47	75	-23

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2022	Mar 2021
Equity Capital	11	11	11	11	11	11	0.19
Reserves	624	616	620	603	602	479	244
Borrowings	393	396	339	317	269	22	34
Other Liabilities	158	141	111	123	90	33	18
Total Liabilities	1186	1164	1080	1054	972	544	296
Fixed Assets	733	583	536	480	336	189	120
CWIP	159	251	233	217	267	32	22
Investments	0	0	0	0	0	0	0
Other Assets	295	330	311	357	369	323	153
Total Assets	1186	1164	1080	1054	972	544	296

Delivery

Delivery Data: TARSONS

#	Date	245 53% 375	Value (Cr)	Q/T 59	Del 31	Del 9
1	4-Sep	336	2	33	43	1
2	3-Sep	336	7	46	38	3
3	2-Sep	345	4	28	42	2
4	1-Sep	344	8	34	40	3
5	31-Aug	332	2	24	49	1
6	28-Aug	332	3	23	48	1
7	27-Aug	329	8	28	27	2
8	26-Aug	343	3	31	42	1
9	25-Aug	346	4	32	36	1
10	24-Aug	347	5	32	38	2
11	21-Aug	345	6	34	43	2
12	20-Aug	337	5	38	35	2
13	19-Aug	343	12	38	22	3
14	18-Aug	337	41	54	20	8
15	17-Aug	362	74	64	14	10
16	14-Aug	360	346	72	5	17
17	13-Aug	313	3	28	33	1
18	12-Aug	313	52	44	10	5
19	11-Aug	297	14	39	41	6
20	10-Aug	314	8	36	37	3
21	7-Aug	312	3	29	46	1
22	6-Aug	318	4	31	56	2
23	5-Aug	328	3	29	48	2
24	4-Aug	324	6	41	55	3
25	3-Aug	317	3	40	58	2
26	31-Jul	315	4	29	45	2
27	30-Jul	316	1	32	53	1
28	29-Jul	320	4	37	49	2
29	28-Jul	311	2	27	46	1
30	27-Jul	321	7	42	49	3
31	24-Jul	313	5	33	38	2
32	23-Jul	317	5	33	34	2
33	22-Jul	306	16	51	26	4
34	21-Jul	312	219	70	6	12
35	20-Jul	281	2	33	51	1
36	17-Jul	287	4	39	53	2
37	16-Jul	300	3	27	46	1
38	15-Jul	298	3	34	58	2
39	14-Jul	309	6	37	46	3
40	13-Jul	316	18	47	40	7
41	10-Jul	303	9	36	37	3
42	9-Jul	289	4	42	32	1
43	8-Jul	290	12	41	25	3
44	7-Jul	296	60	55	10	6
45	6-Jul	293	245	95	6	15
46	3-Jul	267	3	31	32	1
47	2-Jul	265	2	33	37	1
48	1-Jul	262	3	28	42	1
49	30-Jun	268	7	42	29	2
50	29-Jun	260	3	38	40	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	1,777c	39c	2.14
03-Sep	1,816c	13c	0.71
01-Sep	1,803c	41c	2.32
31-Aug	1,762c	11c	0.61
27-Aug	1,752c	70c	3.86
26-Aug	1,822c	14c	0.75
25-Aug	1,836c	4c	0.23
24-Aug	1,831c	38c	2.14
21-Aug	1,793c	27c	1.49
19-Aug	1,820c	22c	1.21
18-Aug	1,798c	138c	7.14
17-Aug	1,937c	38c	1.91
14-Aug	1,975c	330c	20.10
13-Aug	1,644c	11c	0.64
12-Aug	1,655c	15c	0.92
11-Aug	1,670c	0	0
10-Aug	1,670c	21c	1.26
07-Aug	1,649c	107c	6.09
06-Aug	1,756c	59c	3.45
04-Aug	1,698c	5c	0.28
31-Jul	1,703c	19c	1.11
30-Jul	1,684c	4c	0.22
29-Jul	1,680c	19c	1.12
28-Jul	1,662c	41c	2.41
27-Jul	1,703c	51c	3.06
24-Jul	1,652c	0	0

Stock Checklist

Price is above from 52 week high low average: 81%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	+0.01%	0

Tarsons Products Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements